fashion -WSS

fashion

author：hotspot 2025-10-01 17:20:55 - browse：7

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Slovenia has suffered its worst

WSS

Artificial intelligence use in health care faces greater scrutiny in 2024

Ebola vaccine can save some who are already sick, per new study

Study gives hint on South Asians’ higher risk of cardiovascular disease

NFL doctors' conflicts of interest could endanger players, report says

Trump used to be more articulate. What could explain the change?

Eli Lilly reports tirzepatide MASH success during Q4 earnings

explore

fashion

knowledge

What does generative AI mean for health care? We asked experts

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Cancer drug shortages should be causing more outrage

Slovenia has suffered its worst

ChatGPT in medicine: STAT answers readers' burning questions

Doctors on social media are being harassed and cyberbullied

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Flash flood warnings continue for parts of Missouri, Illinois

Trump demands the U.S. pay no more for drugs than other countries … again

Study gives hint on South Asians’ higher risk of cardiovascular disease

knowledge

Too many hospitalized Covid

Too many hospitalized Covid

'Brian's Song' at 50 still offers lessons about cancer for today

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Doctors push to include dialysis machines in emergency stockpile

Trump used to be more articulate. What could explain the change?

focus

hotspot

hotspot

focus